44 results
Page 2 of 3
6-K
EX-99.1
5y286m
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
xu6czwtnqvykov5h1st6
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.1
jou5k0tddraphaki b6
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
424B4
fhwbhx778vh2nfea
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
rtv8y0y6kz lad81ikt
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
agyh8uv7
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
6081bf
18 Dec 20
Draft registration statement
12:00am
6-K
EX-10.1
sque u92cub
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
mju3h5 erlkjb44l
9 Sep 20
Amryt Announces Positive Top Line Results from Pivotal Phase 3 “Ease” Trial of Filsuvez(r) In Epidermolysis Bullosa
8:23am
424B4
yxel908q7o9b6vv
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
jz4yooh xscyel
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
EX-2.2
sbff lfj6
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.2
l0vkla67hi3hxr4
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.1
yrgiu1ty5qxs mcl0ko5
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.5
dt0l39 b3y5
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.3
yj23c ap39
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
bct ol73cqz6tkwz0y
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.7
03ndqg
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
6cw5biy l0kcqpp6
29 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.5
qsoc57qbw
11 May 20
Draft registration statement (amended)
12:00am